Health Alert: Food and Drug Administration wins groundbreaking case against for-profit stem cell company

In a decision expected to send a chill through the stem cell industry, a federal judge ruled in favor of the FDA Monday in a suit against a Florida-based stem cell company whose treatments had blinded at least four patients. Judge Ursula Ungaro said the FDA has the authority to regulate a common procedure in the burgeoning industry – using stem cells derived from patients' fat. The judge did not order the company, U.S. Stem Cell, to halt the procedures, but she is expected to issue an injunction shortly.

Democracy Dies in Darkness     Health Alert Jun 3, 6:32 PM     Food and Drug Administration wins groundbreaking case against for-profit stem cell company In a decision expected to send a chill through the stem cell industry, a federal judge ruled in favor of the FDA Monday in a suit against a Florida-based stem cell company whose treatments had blinded at least four patients. Judge Ursula Ungaro said the FDA has the authority to regulate a common procedure in the burgeoning industry – using stem cells derived from patients' fat. The judge did not order the company, U.S. Stem Cell, to halt the procedures, but she is expected to issue an injunction shortly. Read more » Advertisement You received this email because you signed up for news alerts from The Washington Post. Manage my newsletters and alerts | Unsubscribe Privacy Policy | Help ©2019 The Washington Post, 1301 K St NW, Washington DC 20071